Prolectin-M Uses, Dosage, Side Effects and more

Prolectin-M is a (1-6)-alpha-D-mannopyranose and acts as an antagonist of galectin. It is being investigated in the clinical trial NCT04512027 (Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. (Prolectin-M)).

Trade Name Prolectin-M
Generic Prolectin-M
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

How Prolectin-M works

Prolectin-M antagonizes galectin. It is currently being investigated against COVID-19.

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share